Krystal Biotech (KRYS) Shareholder's Equity (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.69% |
| Dec 31, 2025 | 7.18% |
| Sep 30, 2025 | 9.34% |
| Jun 30, 2025 | 5.68% |
| Mar 31, 2025 | 4.05% |
| Dec 31, 2024 | 6.83% |
| Sep 30, 2024 | 5.60% |
| Jun 30, 2024 | 4.96% |
| Mar 31, 2024 | 2.65% |
| Dec 31, 2023 | 3.00% |
| Sep 30, 2023 | 15.75% |
| Jun 30, 2023 | 33.41% |
| Mar 31, 2023 | -6.25% |
| Dec 31, 2022 | -3.43% |
| Sep 30, 2022 | -3.29% |
| Jun 30, 2022 | 1.94% |
| Mar 31, 2022 | -7.58% |
| Dec 31, 2021 | 45.40% |
| Sep 30, 2021 | -2.46% |
| Jun 30, 2021 | -2.81% |
| Mar 31, 2021 | 47.44% |
| Dec 31, 2020 | -3.19% |
| Sep 30, 2020 | -2.58% |
| Jun 30, 2020 | 56.12% |
| Mar 31, 2020 | -2.24% |
| Dec 31, 2019 | -2.28% |
| Sep 30, 2019 | 4.72% |
| Jun 30, 2019 | 81.11% |
| Mar 31, 2019 | -3.30% |
| Dec 31, 2018 | 116.53% |
| Sep 30, 2018 | 15.51% |
| Jun 30, 2018 | -4.49% |
| Mar 31, 2018 | -4.19% |
| Dec 31, 2017 | -1.44% |